All the latest news on deals and dealmaking from around the world

Halliburton-Baker Hughes call off tie-up

$28bn deal terminated due to regulatory approval challenges


Investment banking league tables
This quarter’s global mergers and acquisitions activity and the deals and dealmakers involved

Hidden loans prove costly for Mozambique

IMF suspends financial aid as worst crisis since civil war deepens

Nokia targets digital healthcare devices

New strategy comes after takeover of French tech group Withings

Liberty House confirms bid for Tata Steel

Sanjeev Gupta’s trading company says it will make a bid this week

Canadian pharma raises NHS eye drug price 14-fold

Concordia strategy triggers fears over price gouging


illustration of a private bank by Øivind Hovland ©Øivind Hovland

Switzerland, strategies, competition, crisis fallout, technology, emerging markets, recruitment, consolidation

illustration by Nick Lowndes ©Nick Lowndes

Insight into M&A in the technology, media and tele-communications sector

Verdi - I Due Foscari at the Scala, Milan with Plácido Domingo

Parmalat: hard cheese

Taking the group private would end a tragedy of operatic proportions

A pedestrian walks past the headquarters of Kleinwort Benson, which are housed in a Commerzbank building in London, UK., on Thursday, Oct. 15, 2009. RHJ International SA agreed to buy Kleinwort Benson, the U.K. private bank from Commerzbank AG for 225 million pounds ($362million) as the firm begins to build a financial services brand. Photographer: Jason Alden/Bloomberg

Commerzbank looks to build on gains

Investors and analysts want CEO Martin Zielke to bolster returns

Pub groups wake up and smell the coffee

The line between bars and coffee shops is increasingly blurred

BLACK AND WHITE ONLY File photo dated 25/02/77 of the then Williams and Glyn's bank in the Cheshire village of Prestbury, near Macclesfield, as the Church of England's investment arm is to have a stake in the running of 314 bank branches being hived off by state-backed Royal Bank of Scotland as part of a £600 million deal, under the deal, the Williams & Glyn business will return to the high street as a "challenger bank" to the major players in the industry, with a particular focus on small business banking - a sector seen as vital to the UK's recovery.

The long saga of selling Williams & Glyn

RBS carve-out has taken five years — and may take another two

Clydesdale Bank and Yorkshire Bank.

Clydesdale and Yorkshire develops AI app

Bank to launch app as customers demand digital banking

Chinese lend $12bn for Russian gas plant

Boost for Putin’s flagship project after US sanctions

Pressure grows on Green over BHS

Sir Philip faces grilling on pension deficit and chain’s collapse

LONDON, UNITED KINGDOM - FEBRUARY 16: Philip Green and Kate Moss are sighted arriving at Unique A/W14 catwalk show during London Fashion Week on February 16, 2014 in London, England. (Photo by Tom Phelan/GC Images)

BHS: A dealmaker’s debacle

Philip Green sold the UK chain for £1 a year ago but he is now under fire following its collapse

M&A: back with a bang

Cash-rich corporates are in the vanguard

Valeant probes revealed in delayed report

Drugmaker staves off default on $30bn and overhauls board

BHS, British Home Stores, on Oxford street, London.
©Charlie Bibby

Pensions chiefs to give evidence on BHS

RBS: refusing to yield

Chances of a dividend payout are diminishing

Manus Island detention center to be closed following PNG Supreme Court decision...epa05279193 A picture dated 21 March 2014 and made available on 27 April 2016 shows asylum seekers staring at media from behind a fence at the Oscar compound in the Manus Island detention center, Papua New Guinea. Papua New Guinea (PNG) Prime Minister Peter O'Neill said on 27 April 2016, that Australia's Manus Island detention center will be closes following a decision by the PNG Supreme Court declaring it as unconstitutional. According to reports, O'Neil urged the Australian government to seek alternative arrangements for asylum seekers. EPA/EOIN BLACKWELL -- BEST QUALITY AVAILABLE -- ATTENTION EDITORS: PICTURE PIXELATED AT SOURCE -- AUSTRALIA AND NEW ZEALAND OUT

Broadspectrum U-turn eases Ferrovial deal

Directors’ change of heart set to call end to takeover battle

Deeper reasons behind BHS pension woes

Reliance on low-yielding bonds eats into the industry

Australia to block vast land sale to China

Sale of Kidman cattle ranch ‘not in the national interest’

Amazon: bouncy castle

There are some rock solid results behind the flighty stock

Gazprom results could fuel payout dispute

Profit rise comes a week after Russian law sets 50% payout rate

Fiat, Alphabet in self-driving car talks

Carmaker wants to hasten push into autonomous vehicle technology

Peter Hambro gold mining

Petropavlovsk recruits partners for growth

UK-listed Russia gold miner moves to rebuild

RBS warns of risk to W&G sale deadline

‘Complexities’ of process blamed in push to sell challenger bank

Pharma deals reignite M&A boom

Abbott, AbbVie and Sanofi in separate tie-ups worth $45bn

EU near to ending CDS investigation

Brussels says it has won concessions from Markit and Isda

NBCUniversal buys DreamWorks Animation

Deal for ‘Shrek’ maker to add content and expand parks

Shell chairman joins new climate group

Charles Holliday to sit on body looking at curbing fossil fuels

Rising duration poses bond risks

Investors embrace danger of longer-dated paper


AbbVie-Stemcentrx move fuels pharma deals

Drugmaker hopes biotech will reduce reliance on blockbuster medicine

Abbott to buy St Jude in $25bn deal

Acquisition of medical devices group resumes pharma merger spree

C90G6D Radisson Hotel Blue Astrid a luxury hotel at the Koningin Astridplein square city centre Antwerp Anvers Flanders Belgium Benelux
©LOOK Die Bildagentur der Fotografen GmbH / Al

HNA in race to grab Chinese tourists

Hainan-based group acquires Carlson Hotels

A worker at Sanofi's dengue vaccine plant in Neuville-sur-Saone, France is seen in this undated handout image released to the media on Friday, Aug. 2, 2013. Sanofi is making the first batches of a dengue vaccine at its new 300 million-euro ($398 million) plant, even as it waits for results next year of make-or-break trials to determine whether the product will be a $2.6 billion-a-year success or an $800 million flop. Photographer: Vincent Moncorge/Sanofi via Bloomberg

Sanofi makes $9.3bn bid for Medivation

French pharmaceuticals group aims to be leader in oncology

IMF plans mission to Tajikistan

Talks over bailout package appear to be gaining urgency

Ackman admits fault in Valeant investment

Hedge fund billionaire in mea culpa as drug prices put under pressure

Competition and Markets Authority booklets

ICE’s $650m Trayport deal set for lengthy probe

UK Competition and Markets Authority likely to launch probe

Patrick Drahi to sell media assets to SFR

Move described as way of using content more effectively

PPF rejected BHS pension offers

Rescue fund deemed proposals inadequate

Landlords face struggle to fill BHS sites

Retailer failed to modernise much of its oversized portfolio